The U.S. Food and Drug Administration announced today that it has approved Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G)-(Equine) to treat patients showing signs of botulism following documented or suspected exposure to botulinum neurotoxin. The product is derived from horse plasma and contains a mixture of antibody fragments that neutralize all of [...]
Read More...Categories
FDA Recalls
- This feed (or Twitter.com) is having issues at this time, please check back later.
FDA Drug Info
- This feed (or Twitter.com) is having issues at this time, please check back later.
FDA Medical Device
- This feed (or Twitter.com) is having issues at this time, please check back later.
FDA Medication Watch
- This feed (or Twitter.com) is having issues at this time, please check back later.
Tags
Alert Alerts Allergy announces approves Because Brand Certain Class Communication Consumer Contamination Dietary Drug Drugs Feed first food Foods from Health Inc. Ingredient Injection Issues Mediation Medical Milk Nationwide Possible Potential Press product Products Recall Recalls Releases Risk Safety system treat Undeclared Voluntarily Voluntary Watch